Driving progress in cancer research means seeing the forest and the trees at the same time. This balanced approach is essential because tumors are complex ecosystems shaped by diverse cell types and their interactions with the surrounding microenvironment. To truly understand the mechanisms behind cancer initiation, progression, and treatment resistance, researchers need technologies that capture both the molecular details and the broader spatial architecture of tumors.
Today, new technologies are transforming researchers' perspectives on cancer. Single-cell analysis combined with spatial mapping enables scientists to explore cancer biology across multiple dimensions. These approaches are uncovering patterns and interactions that were once hidden from view. The results? New windows into cancer's biology and new opportunities to transform diagnosis and treatment.
Zooming in and out: A new way to study cancer
Single-cell sequencing allows scientists to explore the roles of individual cell types within tumors. However, traditional single-cell RNA and DNA sequencing methods have limitations, particularly when it comes to throughput (the number of cells analyzed in a single experiment)
Historically, researchers have been limited to two choices in single-cell sequencing: analyze a small number of cells in great detail or survey many cells with limited sensitivity and coverage. Neither option is ideal. Sequencing only a few cells risks missing the tumor’s broader cellular diversity, whereas analyzing more cells often sacrifices the depth of information needed to detect subtle but important molecular features within individual cells.
Emerging high-throughput methods are helping to resolve this dilemma by enabling the analysis of thousands of cells in a single experiment without sacrificing sensitivity or genomic coverage. This leap in capability improves the statistical power of studies and opens new avenues for understanding tumor heterogeneity, treatment resistance, and disease progression.
But understanding cancer isn't just about profiling individual cells. It also involves knowing where those cells are and how they interact. Spatial omics—methods that preserve the spatial location of molecular data, such as RNA or proteins, within intact tissue samples—have emerged to fill this gap. By aligning gene expression or other molecular signals to tissue architecture, this technology provides a much richer context for biological discovery.
As with earlier single-cell techniques, spatial methods provided either high resolution or broad coverage, forcing researchers to choose between zooming in on cellular detail or zooming out to capture larger tissue organization. New, scalable methods, such as Slide-seq, are helping to overcome these limitations.
Slide-seq is a spatial transcriptomics technology that transfers RNA from tissue sections onto a surface covered with barcoded beads, each carrying a known spatial position. This setup allows researchers to map gene expression across intact tissue sections with near-single-cell resolution. By capturing the identity of transcripts and their precise locations within the tissue, Slide-seq enables high-resolution, genome-wide analysis of tumors' cellular organization and microenvironment.
With tools like Slide-seq, scientists can do much more than catalog which genes are active. They can track the interactions between cancer cells and their surroundings, including immune cells, support tissues, and blood vessels. It is also possible to map how growth signals spread through the tumor, observe how cancer cells avoid immune attacks, and identify areas within the tumor that may fuel its evolution.
Advanced Lab Management Certificate
The Advanced Lab Management certificate is more than training—it’s a professional advantage.
Gain critical skills and IACET-approved CEUs that make a measurable difference.
These capabilities allow scientists to view cancer as a dynamic, spatially organized disease rather than just a collection of rogue cells.
Scaling data needs
The revolution in resolution comes at a cost—vast and complex data. Modern single-cell and spatial sequencing experiments generate huge datasets that must be carefully processed, analyzed, and interpreted to produce meaningful biological insights. Without robust computational support, the biological signals hidden within these datasets would be difficult, if not impossible, to uncover.
Processing and interpreting this information requires workflows tailored to specific biological questions.
For biomarker discovery, analytics pipelines must reveal subtle gene expression patterns across diverse cell populations, capturing rare or heterogeneous groups that could be clinically significant.
For genomic analysis, analytic workflows are needed to detect copy number variations as well as both germline and somatic single-nucleotide variants, offering insights into cancer's genetic drivers and evolution.
Cell-specific RNA and DNA profiling require highly sensitive analytic pipelines that distinguish molecular signatures across individual tumor cells. These workflows should enable researchers to characterize functional differences between malignant and non-malignant cells, uncover transcriptional programs linked to therapy resistance, and track genetic alterations that may drive clonal evolution within the tumor microenvironment.
Interested in life sciences?
While many research groups have the expertise to build custom pipelines, developing and validating these tools is often resource- and time-intensive. Today, a growing range of commercial and open-source solutions offer alternatives to in-house pipeline development. These platforms provide ready-to-use workflows that make high-level analysis more accessible, even for teams without specialized bioinformatics support. By handling the complexity of data processing and analytics, these solutions allow oncology researchers to focus on biological interpretation rather than the technical demands of building custom tools from scratch.
Looking ahead
The ability to capture both molecular minutiae and spatial relationships is reshaping how we approach cancer research. As resolution increases, so does the responsibility to manage, analyze, and interpret the resulting complex datasets with rigor and clarity.
